ProUroCare Medical Correlations
| PUMD Stock | USD 0.0002 0.00 0.00% |
The correlation of ProUroCare Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
ProUroCare | Build AI portfolio with ProUroCare Stock |
Moving together with ProUroCare Stock
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between ProUroCare Stock performing well and ProUroCare Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ProUroCare Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| LIPO | 5.80 | (0.96) | 0.00 | (0.36) | 0.00 | 14.29 | 34.87 | |||
| SLRX | 6.29 | (2.00) | 0.00 | (2.13) | 0.00 | 15.01 | 66.07 | |||
| SLXN | 3.88 | (0.82) | 0.00 | (0.21) | 0.00 | 9.80 | 28.03 | |||
| INDP | 6.70 | 0.02 | 0.03 | 0.07 | 7.76 | 16.82 | 37.41 | |||
| PTIX | 4.14 | (0.74) | 0.00 | (0.60) | 0.00 | 8.24 | 33.23 | |||
| BIAF | 7.63 | (1.72) | 0.00 | (0.37) | 0.00 | 24.49 | 93.70 | |||
| SPRC | 9.68 | 1.39 | 0.16 | 0.60 | 8.50 | 24.35 | 172.66 | |||
| MNDR | 8.89 | (0.34) | 0.00 | 0.89 | 0.00 | 22.16 | 121.66 | |||
| ARTL | 5.37 | (0.98) | 0.00 | 4.79 | 0.00 | 7.93 | 51.24 | |||
| JSPR | 3.79 | (0.52) | 0.00 | (0.20) | 0.00 | 6.55 | 24.97 |
ProUroCare Medical Corporate Executives
Elected by the shareholders, the ProUroCare Medical's board of directors comprises two types of representatives: ProUroCare Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ProUroCare. The board's role is to monitor ProUroCare Medical's management team and ensure that shareholders' interests are well served. ProUroCare Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ProUroCare Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alan Shuler | CFO and Secretary | Profile |